Meds & supplements › Bromfenac
Medicine
Bromfenac
Bromfenac Ophthalmic Solution 0.09% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Drug facts
- Used for
- Bromfenac Ophthalmic Solution 0.09% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
What it is used for
Bromfenac ophthalmic solution 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
Side effects, and when to stop
The following serious adverse reactions are described elsewhere in the labeling:
- Slow or Delayed Healing [ see Warnings and Precautions ]
- Potential for Cross-Sensitivity [ see Warnings and Precautions ]
- Increased Bleeding Time of Ocular Tissue [ see Warnings and Precautions ]
- Keratitis and Corneal Reactions [ see Warnings and Precautions ]
- Contact Lens Wear [ see Warnings and Precautions ]
Who should not take it
None
Cite this page
- NLM
sofidex [Internet]. Daloreum; c2026. Bromfenac; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/bromfenac
- APA 7th
sofidex. (2026, August 2). Bromfenac. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/bromfenac
- AMA 11th
Bromfenac. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/bromfenac
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.